Risultati della ricerca - Chiaki T. Ishida

  • Mostra 1 - 7 risultati su 7
Raffina i risultati
  1. 1
    Targeting intrinsic apoptosis and other forms of cell death by BH3-mimetics in glioblastoma

    Targeting intrinsic apoptosis and other forms of cell death by BH3-mimetics in glioblastoma di Georg Karpel‐Massler, Chiaki Tsuge Ishida, Yiru Zhang, Marc‐Eric Halatsch, Mike‐Andrew Westhoff, Markus D. Siegelin

    Pubblicazione 2017
    Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  2. 2
    BH3-mimetics and BET-inhibitors elicit enhanced lethality in malignant glioma

    BH3-mimetics and BET-inhibitors elicit enhanced lethality in malignant glioma di Chiaki Tsuge Ishida, Elena Bianchetti, Chang Shu, Marc‐Eric Halatsch, Mike‐Andrew Westhoff, Georg Karpel‐Massler, Markus D. Siegelin

    Pubblicazione 2017
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  3. 3
    Induction of synthetic lethality in IDH1-mutated gliomas through inhibition of Bcl-xL

    Induction of synthetic lethality in IDH1-mutated gliomas through inhibition of Bcl-xL di Georg Karpel‐Massler, Chiaki Tsuge Ishida, Elena Bianchetti, Yiru Zhang, Chang Shu, Takashi Tsujiuchi, Matei A. Banu, Franklin Garcia, Kevin A. Roth, Jeffrey N. Bruce, P. Canoll, Markus D. Siegelin

    Pubblicazione 2017
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  4. 4
    Inhibition of Mitochondrial Matrix Chaperones and Antiapoptotic Bcl-2 Family Proteins Empower Antitumor Therapeutic Responses

    Inhibition of Mitochondrial Matrix Chaperones and Antiapoptotic Bcl-2 Family Proteins Empower Antitumor Therapeutic Responses di Georg Karpel‐Massler, Chiaki Tsuge Ishida, Elena Bianchetti, Chang Shu, Rolando Pérez‐Lorenzo, Basil A. Horst, Matei A. Banu, Kevin A. Roth, Jeffrey N. Bruce, Peter Canoll, Dario C. Altieri, Markus D. Siegelin

    Pubblicazione 2017
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  5. 5
    Metabolic Reprogramming by Dual AKT/ERK Inhibition through Imipridones Elicits Unique Vulnerabilities in Glioblastoma

    Metabolic Reprogramming by Dual AKT/ERK Inhibition through Imipridones Elicits Unique Vulnerabilities in Glioblastoma di Chiaki T. Ishida, Yiru Zhang, Elena Bianchetti, Chang Shu, Trang Nguyen, Giulio Kleiner, Maria J. Sanchez‐Quintero, Catarina M. Quinzii, Mike‐Andrew Westhoff, Georg Karpel‐Massler, Varun V. Prabhu, Joshua E. Allen, Markus D. Siegelin

    Pubblicazione 2018
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  6. 6
    Activation of <scp>LXR</scp> β inhibits tumor respiration and is synthetically lethal with Bcl‐ <scp>xL</scp> inhibition

    Activation of <scp>LXR</scp> β inhibits tumor respiration and is synthetically lethal with Bcl‐ <scp>xL</scp> inhibition di Trang Nguyen, Chiaki Tsuge Ishida, Enyuan Shang, Chang Shu, Consuelo Torrini, Yiru Zhang, Elena Bianchetti, Maria J. Sanchez‐Quintero, Giulio Kleiner, Catarina M. Quinzii, Mike‐Andrew Westhoff, Georg Karpel‐Massler, Peter Canoll, Markus D. Siegelin

    Pubblicazione 2019
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  7. 7
    Combined HDAC and Bromodomain Protein Inhibition Reprograms Tumor Cell Metabolism and Elicits Synthetic Lethality in Glioblastoma

    Combined HDAC and Bromodomain Protein Inhibition Reprograms Tumor Cell Metabolism and Elicits Synthetic Lethality in Glioblastoma di Yiru Zhang, Chiaki Tsuge Ishida, Wataru Ishida, Sheng-Fu Larry Lo, Junfei Zhao, Chang Shu, Elena Bianchetti, Giulio Kleiner, Maria J. Sanchez‐Quintero, Catarina M. Quinzii, Mike‐Andrew Westhoff, Georg Karpel‐Massler, Peter Canoll, Markus D. Siegelin

    Pubblicazione 2018
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:

Strumenti per la ricerca: